AquaBounty Technologies (AQB) Expected to Announce Quarterly Earnings on Tuesday

AquaBounty Technologies (NASDAQ:AQB) is expected to be posting its results before the market opens on Tuesday, March 10th. Analysts expect AquaBounty Technologies to post earnings of ($0.52) per share and revenue of $0.50 million for the quarter.

AquaBounty Technologies Trading Down 0.3%

NASDAQ:AQB opened at $0.93 on Friday. The stock has a market cap of $3.60 million, a price-to-earnings ratio of -1.12 and a beta of 1.29. The company has a 50-day moving average price of $0.93 and a 200-day moving average price of $1.15. AquaBounty Technologies has a 12 month low of $0.50 and a 12 month high of $2.95.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of AquaBounty Technologies in a research report on Monday, December 22nd. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, AquaBounty Technologies has a consensus rating of “Sell”.

Hedge Funds Weigh In On AquaBounty Technologies

An institutional investor recently raised its position in AquaBounty Technologies stock. Renaissance Technologies LLC boosted its stake in shares of AquaBounty Technologies, Inc. (NASDAQ:AQB) by 311.9% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 121,585 shares of the company’s stock after acquiring an additional 92,065 shares during the period. Renaissance Technologies LLC owned 3.14% of AquaBounty Technologies worth $113,000 at the end of the most recent quarter. 8.92% of the stock is currently owned by institutional investors.

AquaBounty Technologies Company Profile

AquaBounty Technologies, Inc is a biotechnology company focused on aquaculture innovation through the development and commercialization of genetically engineered fish. Its flagship product, AquAdvantage Salmon, is an Atlantic salmon strain enhanced with a growth hormone gene that enables faster growth and more efficient feed conversion compared with conventional farmed salmon. By integrating biotechnology into seafood production, AquaBounty aims to address global protein demand while reducing the environmental footprint associated with marine aquaculture.

Founded in 1991, AquaBounty is headquartered in Maynard, Massachusetts, and operates a state-of-the-art, land-based incubation and grow-out facility in Panama.